Comparative Anti-Obesity Activity of Probiotics with Short-Chain Fatty Acids (SCFAs) Through GLP 1 and PYY Activity in High Fat Diet Induces Obesity in Rats
Abstract:
Microbiota
in the intestine produces SCFAs like Butyrate and Propionate through undigested
fiber, which plays an important role in metabolic disorders, especially in
obesity and type II diabetes. To compare the anti-obesity activity of probiotics
with SCFAs through GLP-1 and PYY activity in HFD induced obesity in rats. For
the study, rats weighing around 150-200g were chosen, separated into multiple
groups, and given Fat-enriched diet for 12 weeks to trigger obesity. SCFAs like
Butyrate, propionate (400mg/kg, P.O), and probiotics (108 CFU P.O)
were continuously administered to their groups along with the HFD. Weekly once
the animal's BW & daily food intake by the animal, and every 15 days once
lipid profile, GLP, PYY, insulin, and leptin parameters were measured. After
the completion of the study blood was collected through retro-orbital puncture
for evaluation of biochemical parameters and animals were anesthetized and
sacrificed for organ isolation for histopathological studies. Administration of
SCFAs along with Probiotics in HFD-induced Overweight rats led to a notable
drop in BW, food intake, fat accumulation, fasting insulin, leptin, and lipids throughout
12 weeks as compared with rats fed with HFD and standard. SCFAs along with
probiotics effectively increase HDL levels and reduce LDL. Histopathology
examination reveals that fat tissue accumulation was absent in treated groups
when compared with only the HFD feed group. Results show that SCFAs are showing
a notable decrease in lipid profile, food intake, and body weight than probiotics-treated
group possesses significant anti-obesity activity.
References:
[1]. Bhutani, K. K., Birari, R., Kapat, K., 2007, Potential
Anti-Obesity and Lipid Lowering Natural Products: A Review. Natural Product
Communications,2(3). https://doi:10.1177/1934578X0700200316
[2]. Mopuri, R., Ganjayi, M., Banavathy, K. S., Parim, B. N., Meriga, B.,
2015, Evaluation of Anti-Obesity Activities of Ethanolic Extract of Terminalia
Paniculata Bark on High Fat Diet-Induced Obese Rats. BMC Complement Altern
Med. Mar 24,15,76. https://doi:10.1186/s12906-015-0598-3
[3]. Yuan, H. -D., Kim, S. -J.; Quan, H.-Y., Huang, B., Chung, S. -H., 2010, Ginseng Leaf Extract Prevents
High Fat Diet-Induced Hyperglycemia and Hyperlipidemia Through AMPK Activation.
J. Ginseng Res. 34, 369–375. https://doi.org/10.5142/jgr.2010.34.4.369
[4]. Saravanan, G., Ponmurugan, P., Deepa, M. A., Senthilkumar, B., 2014,
Anti-Obesity Action of Gingerol: Effect on Lipid Profile, Insulin, Leptin,
Amylase and Lipase in Male Obese Rats Induced by a High-Fat Diet. J Sci Food
Agric, Nov, 94(14), 2972-7. https://doi:10.1002/jsfa.6642
[5]. Jura, M., Kozak, L. P., 2016, Obesity and Related Consequences to Ageing,
Age (Dordr). Feb;38(1):23. https://doi:10.1007/s11357-016-9884-3
[6]. Dietz, W. H., Baur, L. A., Hall, K., Puhl, R. M.,
Taveras, E. M., Uauy, R., Kopelman, P., 2015 Management of Obesity: Improvement
of Health-Care Training and Systems for Prevention and Care. Lancet. Jun
20;385(9986):2521-33. https://doi:10.1016/S0140-6736(14)61748-7
[7]. Kaczmarczyk, M. M., Miller, M. J., 2012, The Health
Benefits of Dietary Fiber: Beyond the Usual Suspects of Type 2 Diabetes
Mellitus, Cardiovascular Disease and Colon Cancer. Metabolism: Clinical and
experimental, 61(8), 1058–1066. https://doi.org/10.1016/j.metabol.2012.01.017
[8]. Edwards, C. A., Xie, C., Garcia, A. L., 2015, Dietary Fibre and Health
in Children and Adolescents. Proc Nutr Soc. Aug;74(3):292-302. https://doi:10.1017/S0029665115002335
[9]. Liu, X., Wu, Y., Li, F., Zhang, D., 2015, Dietary Fiber Intake Reduces
Risk of Inflammatory Bowel Disease: Result from a Meta-Analysis. Nutr Res.
Sep,35(9),753-8. https://doi:10.1016/j.nutres.2015.05.021
[10]. Keenan, M. J, Zhou, J., Hegsted, M., Pelkman, C., Durham, H. A., Coulon,
D. B., Martin, R. J., 2015 Role of Resistant Starch in Improving Gut Health,
Adiposity, and Insulin Resistance. Adv Nutr, 6(2),198-205. https://doi:10.3945/an.114.007419
[11]. Anastasovska, J., Arora, T., et al. 2012, Fermentable
carbohydrate Alters Hypothalamic Neuronal Activity and Protects Against the
Obesogenic Environment, 20(5), 1016–1023. https://doi.org/10.1038/oby.2012.6
[12]. Wanders, A. J., van den Borne, J. J., et.al, 2011,
Effects of Dietary Fibre on Subjective Appetite, Energy Intake and Body Weight:
A Systematic Review of Randomized Controlled Trials, 12(9), 724–739. https://doi.org/10.1111/j.1467-789X.2011.00895.x
[13]. Tan, J., McKenzie, C., Potamitis, M., et.al. 2014, The
Role of Short-Chain Fatty Acids in Health and Disease. Advances in Immunology,
121, 91–119. https://doi.org/10.1016/B978-0-12-800100-4.00003-9
[14]. Canfora, E. E., Jocken, J. W., & Blaak, E. E.,
2015, Short-Chain Fatty Acids in Control of Bodyweight and Insulinsensitivity,11(10),577591.https://doi.org/10.1038/nrendo.2015.128
[15]. Tazoe, H., Otomo, Y., Karaki, S., Kato, I., Fukami,
Y., Terasaki, M., & Kuwahara, A. 2009, Expression of Short-Chain Fatty Acid
Receptor GPR41 in the Human Colon. Biomedical Research, 30(3), 149–156. https://doi.org/10.2220/biomedres.30.149
[16]. Samuel, B. S., Shaito, A., Motoike, T., et.al 2008, Effects
of the Gut Microbiota on Host Adiposity are Modulated by the Short-Chain
Fatty-Acid Binding G Protein-Coupled Receptor, Gpr41, 105(43), 16767–16772. https://doi.org/10.1073/pnas.0808567105
[17]. Nemet, I., et al. 2020, A Cardiovascular
Disease-Linked Gut Microbial Metabolite Acts Via Adrenergic Receptors.Cell,180(5),862–877.e22.https://doi.org/10.1016/j.cell.2020.02.016
[18]. Chaudhary, P. K., & Kim, S., 2021, An Insight into
GPCR and G-Proteins as Cancer Drivers. Cells, 10(12), 3288. https://doi.org/10.3390/cells10123288
[19]. OECD 2008, Test No. 407: Repeated Dose 28-day Oral
Toxicity Study in Rodents, OECD Guidelines for the Testing of Chemicals,
Section 4, OECD Publishing, Paris, https://doi.org/10.1787/9789264070684-en
[20]. Luna, L. G., 1968, Manual of Histologic Staining
Methods of the Armed Forces Institute of Pathology. 3rd Edition, McGraw-Hill,
New York.p. 258.
[21]. Kim, A., -Young & Jeong, et.al 2012, Dose Dependent Effects of
Lycopene Enriched Tomato-Wine on Liver and Adipose Tissue in High-Fat Diet Fed
Rats, 130. 42-48. https://doi.org/10.1016/j.foodchem.2011.06.050
[22]. BrahmaNaidu, P., et.al 2014, Mitigating Efficacy of Piperine in the
Physiological Derangements of High Fat Diet Induced Obesity in Sprague Dawley Rats,
221, 42–51. https://doi.org/10.1016/j.cbi.2014.07.008
[23]. Shah, S. S., et.al 2011, Effect of Piperine in the Regulation of
Obesity-Induced Dyslipidemia in High-Fat Diet Rats. Indian Journal of
Pharmacology, 43(3), 296–299. https://doi.org/10.4103/0253-7613.81516
[24]. Johnson, R., McNutt, P., MacMahon, S., & Robson, R., 1997, Use of the
Friedewald Formula to Estimate LDL-Cholesterol in Patients with Chronic Renal
Failure on Dialysis. Clinical Chemistry, 43(11), 2183–2184.
[25]. Muruganandan, S., Srinivasan, K., Gupta, S., Gupta, P. K., & Lal, J.,
2005, Effect of Mangiferin on Hyperglycemia and Atherogenicity in
Streptozotocin Diabetic Rats, 97(3), 497–501. https://doi.org/10.1016/j.jep.2004.12.010
[26]. Suanarunsawat, T., et.al 2010, Antioxidant Activity and Lipid-Lowering
Effect of Essential Oils Extracted from Ocimum Sanctum L. Leaves in Rats Fed
with a High Cholesterol Diet. Journal of Clinical Biochemistry and
Nutrition, 46(1), 52–59. https://doi.org/10.3164/jcbn.09-52
[27]. Kimura, I., et.al 2011, Short-Chain Fatty Acids and Ketones
Directly Regulate Sympathetic Nervous System Via G Protein-Coupled Receptor 41
(GPR41), 108(19), 8030–8035. https://doi.org/10.1073/pnas.1016088108